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Pseudoautosomal Linkage of Hodgkin Disease
To the Editor:
We wish to thank Horwitz and Wiernik for their inter-
esting paper “Pseudoautosomal Linkage of Hodgkin
Disease” (Horwitz and Wiernik 1999), even though we
disagree with some of their conclusions. The authors
combined two findings from the literature to propose a
new direction in the genetic epidemiology of Hodgkin
disease. The first finding is that of a pair of sisters con-
cordant for both Hodgkin disease (MIM 236000) and
the rare disorder Leri-Weill dyschondrosteosis (LWD)
(MIM 127300) (Gokhale et al. 1995). The second find-
ing is that LWD results from mutations and large de-
letions of the SHOX homeobox gene on the pseudoau-
tosomal region of the short arms of the X and Y
chromosomes (Belin et al. 1998; Shears et al. 1998).
Horwitz and Wiernik conjecture that a gene for Hodgkin
disease may also lie in this region.
This conjecture predicts an excess of sex concordance
among pairs of relatives with Hodgkin disease, an excess
that, in fact, has been reported for sibs (Grufferman et
al. 1977). To investigate this prediction in a larger data
set, Horwitz and Wiernik evaluated sex concordance in
102 affected sib pairs (ASPs) gathered from the world’s
literature. They found that 63 (62%) of the pairs were
concordant (41 male-male and 22 female-female). Part
of this excess concordance is likely explained by the
higher incidence of Hodgkin disease among males than
among females. After allowing for this fact, the authors
conclude that the excess concordance is not statistically
significant. They base their conclusion on the value 4.40
of a x2 test on 2 df ( ). In fact, the excess is statis-P 1 .2
tically significant, because the value 4.40 of the likeli-
hood ratio statistic of the null hypothesis of no concor-
dance, allowing for a male excess risk, should be referred
to a x2 distribution on 1 df ( ).P ! .05
To further investigate their conjecture, Horwitz and
Wiernik conducted a linkage analysis of the pseudoau-
tosomal region, using sexual phenotype as the marker
and based on the sex distribution within a sample of
multiple-case families obtained from the literature and
from Montefiore Medical Center. On the basis of a para-
metric analysis, the authors report a male recombination
fraction (v) of .254, which they interpret as evidence that
the putative Hodgkin disease gene is in close proximity
to the SHOX locus. Using an analysis based on the beta
model proposed by Morton and colleagues (Morton
1996; Collins and Morton 1996), they conclude that a
putative pseudoautosomal region (PAR) gene accounts
for 29% of Hodgkin disease heritability in the United
States. We believe that the authors have overinterpreted
the results of both these analyses.
They have overinterpreted the results of the paramet-
ric analysis, because the models they fit to the data fail
to account for the probable genetic heterogeneity of the
disease. Instead, the models assume that a PAR gene is
solely responsible for hereditary Hodgkin disease. It is
well known that failure to account for such heteroge-
neity leads to overestimates of v. Evidence that more
than one gene is responsible for hereditary Hodgkin dis-
ease arises not only from data implicating the HLA re-
gion (Berberich et al. 1983; Chakravarti et al. 1986),
but also from the high recurrence risk in MZ twins com-
pared with DZ twins (Mack et al. 1995). Thus the au-
thors are attributing greater precision to the estimate
than is warranted by the data.v = .254male
In an attempt to estimate the fraction of hereditary
Hodgkin disease due to a putative PAR gene, Horwitz
and Wiernik fit Morton’s beta model (Morton 1995;
Collins and Morton 1996) to the sexual phenotypes of
the 102 ASPs. They combined the estimate for beta ob-
tained in this way with sibling recurrence risks from the
literature to produce their 29% estimate. To clarify why
this estimate is inappropriate, it is helpful to review the
beta model. Suppose that there are m unlinked genes
responsible for hereditary Hodgkin disease. The model
assumes that the joint probability that two relatives are
both affected, given their identical-by-descent (IBD)
status for each of the m genes, is
m
2P(D = D = 1FIBD = j ,...,IBD = j ) = K exp j b .[ ]1 2 1 1 m m  
=1
(1)
In this equation, and are indicators for HodgkinD D1 2
disease status, K is the prevalence of disease in the gen-
eral population, denotes IBD status for geneIBD ,
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and measures the log contribution of = 1,...,m, b  0
gene to the sibs’ phenotype correlation, .  = 1,...,m
Equation (1) implies that two sibs are both affected with
probability
P(D = D = 1Fsibs)1 2
2 2 m
2 …= K p(j ,...,j ) exp ( j b ) , (2)  [ ]1 m  
j =0 j =0 =11 m
where
mm1 2p(j ,...,j ) =  (3)1 m ( )( ) j4 =1 
is the joint probability that two sibs share alleles IBDj
at locus , . Substituting equation (3) into  = 1,...,m
equation (2) gives
m b 21 e2P(D = D = 1Fsibs) = K  . (4)1 2 ( )
=1 2
Equation (4) determines the sibling recurrence risk aslS
1l = K P(D = 1FD = 1,sibs)S 2 1
2= K P(D = D = 1Fsibs)1 2
m b 21 e
= . (5)( )
=1 2
According to equation (5), the fractional contribution
of the PAR gene (gene 1) to the recurrence risk islS
b 21[(1 e )/2]
F = . (6)PAR
lS
The parameter is estimable from IBD sharing datab1
in affected sibs, because from equation (2) and Bayes’s
Rule the probability that two affected sibs share j alleles
IBD at the PAR locus 1 is given by
jb1a ejz = , j = 0,1,2 . (7)2j
ib1 a ei
i=0
In this equation, , , and are thea = 1/4 a = 1/2 a = 1/40 1 2
Mendelian probabilities that the sibs share 0, 1, and 2
alleles IBD at the PAR locus. Thus, in principle, one
could (1) estimate from linkage data in the PAR, (2)b1
estimate the sibling recurrence risk from epidemiological
data, and (3) combine these two estimates in equation
(6) to attribute a fractional contribution of hered-FPAR
itary Hodgkin disease to the putative PAR gene. For
example, the estimate , obtained by Horwitzˆb = .5621
and Wiernik, gives , using the recurrence riskF = .01PAR
of Hafez et al. (1985), and it gives ,l = 210 F = .27S PAR
using the value of Grufferman et al. (1977). Whenl = 7S
b1 is close to zero, and equation (6)
b 2 b1 1[(1 e )/2] ∼e
becomes . This approximationF ∼ exp (b  lnl )PAR 1 s
gives for and forF = .01 l = 210 F = .25 l = 7.PAR S PAR S
(Inexplicably, Horwitz and Wiernik used the ratio
for the fraction of hereditary Hodgkin diseaseˆb / lnl1 S
due to a gene in the PAR. Thus, with , theyˆb = .5621
estimated this fraction as .11 for and as .29 forl = 210S
.)l = 7S
In practice, however, such attribution is inappropriate.
It requires the assumption that IBD status at the PAR
gene equals IBD status at the marker (which is an ar-
bitrary sex-specific locus). In fact, the unknown genetic
distance between marker and PAR gene and the un-
known penetrance of the PAR gene (which determines
) are completely confounded: highly penetrant genesb1
more distal from the marker will yield the same estimates
as less-penetrant genes close to the marker.ˆb1
In summary, IBD status at the PAR gene cannot be
inferred from sexual phenotypes of ASPs, and thus equa-
tion (7) cannot be used to estimate . This also can beb1
seen by considering the usual nonparametric ASP test,
which evaluates the mean number of alleles shared at
the marker. ASPs of the same sex share an average of
1.5 marker alleles IBD, whereas ASPs of the opposite
sex share an average of 0.5 such alleles. Letting n denote
the number of sex-concordant pairs among the 102 sib
pairs described by Horwitz and Wiernik, the ASP test is
based on the score constant.1.5n 0.5(102 n) = n
The ASP test statistic is
2(n 102p)2T = ,
102p(1 p)
where p denotes the null frequency of sex-concordant
sib pairs. Using the estimate 2 2P = (.593)  (.407) =
where .593 and .407 are the proportions of males.5173,
and females, respectively, among the 204 sibs, we have
for sex-concordant pairs. This ASP test2T = 4.11 n = 63
simply evaluates the statistical significance of the ob-
served sex concordance among the 102 ASPs, allowing
for excess Hodgkin disease risk in males. In conclusion,
without genotype data for multiple markers in the p-
terminal PAR, the only inferences possible are those con-
cerning the magnitude of any excess sex concordance
among ASPs; it is not possible to infer the location or
relative importance of a PAR gene for Hodgkin disease.
These comments notwithstanding, we are grateful to
the authors for their seminal and potentially important
observations. Further progress in our understanding of
the genetic etiology of Hodgkin disease clearly requires
more detailed marker data among multiple-case families,
both in the PAR and elsewhere in the genome.
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